The Interplay Between Apolipoprotein E4 and the Autophagic–Endocytic–Lysosomal Axis
Abstract
Since its discovery as a genetic risk factor for Alzheimer's disease, the APOE4 allele has been linked to the majority of the pathological findings associated with the disease progression. These include abnormalities of the endocytic, autophagic, and lysosomal machineries, which begin at the most early stages of Alzheimer's disease development. Considering that these three vesicular systems share common features and, in fact, comprise an interconnected cargo-trafficking and degradation network, some of the effects of APOE4 are interrelated, while others are system-specific. In turn, APOE4-driven impairments of endocytosis, autophagy, and lysosomal activity influence various aspects of Alzheimer's disease pathology, ranging from Aβ generation and clearance to neuronal loss and cognitive deficits. This review discusses the detrimental effects of APOE4 on the endocytic-autophagic-lysosomal axis in the context of Alzheimer's disease, as well as the various mechanisms underlying them.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Less autophagosomes-lysosomes fusion in APOE4 astrocytes following CCCP is consistent with other lysosomal dysfunctions associated with APOE4.
“which is consistent with other lysosomal dysfunctions associated with APOE447.”
From Altered mitochondrial dynamics and function in APOE4-expressing astrocytes (2020) · cites this paper as [47]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 96 · Cited by 35
- Authors
- Schmukler, E., Michaelson, D. M., & Pinkas-Kramarski, R.
- Affiliations
- Tel Aviv University (IL)
- ORCID
- Pinkas-Kramarski, R.
- Venue
- Molecular Neurobiology
- Published
- 2018-01-20
- Volume
- 55
- Issue
- 8
- Pages
- 6863-6880
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2785279364
- Cited by
- 35
- References
- 96
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 2
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Prajs-Drimmer Institute for degenerative diseases
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- APOE ε4, Alzheimer's disease, autophagy, endocytosis, lysosomes, cargo trafficking, amyloid-beta clearance, amyloid-beta production, neuronal loss, cognitive impairment, genetic risk factors
- MeSH terms
- Alzheimer Disease, Animals, Autophagy, Endocytosis, Humans, Lysosomes, Models, Biological, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review